Status:
TERMINATED
Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Collaborating Sponsors:
Dr. Sulaiman Alhabib Medical City, Riyadh
Security Forces Hospital
Conditions:
Infant, Very Low Birth Weight
Eligibility:
All Genders
Up to 1 years
Phase:
NA
Brief Summary
To evaluate the efficacy of prophylactic glycerin suppositories will accelerate the elimination of meconium from the large intestine and thus reduce the incidence of feeding intolerance in very low bi...
Eligibility Criteria
Inclusion
- Preterm infants with birth weight \< 1250g.
- Inborn or outborn infants
- Less than 72 hours of age.
Exclusion
- Congenital malformations.
- Acute abdomen needing surgical intervention.
- Severity of illness such that death is likely in the first few days after birth.
- Inability to get the parental consent.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT01799629
Start Date
March 1 2013
End Date
December 1 2022
Last Update
March 6 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia, 11211
2
Security Forces Hospital
Riyadh, Saudi Arabia
3
Sulaiman Al habib Medical Center
Riyadh, Saudi Arabia